This agent is being developed in support of ongoing phase I/II clinical trials, therefore the product is needed to be produced under the GMP condition using the process used to produce lot number…
Ended Awarded Last action
- Contract number
- 75N91019F00111
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $176,862
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $176,862.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on January 7, 2019, with a ceiling value of $176,862.00 for manufacturing Indenos (LMP744, NSC 706744) for injection, 50 milliliter fill, under Good Manufacturing Practice conditions using the process employed for lot number 15LM092 in support of Phase I/II clinical trials.
Place of performance is San Diego, CA 92121. The order is cost-plus-fixed-fee and concludes October 6, 2019. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business subsidiary of Irisys, Inc., a contract development and manufacturing organization specializing in pharmaceutical product development and manufacturing for federal agencies.
Description
This agent is being developed in support of ongoing phase I/II clinical trials, therefore the product is needed to be produced under the GMP condition using the process used to produce lot number 15LM092.
Quick answers
Who was awarded contract 75N91019F00111?
75N91019F00111 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on January 7, 2019.
How much is contract 75N91019F00111 worth?
The government has obligated $176,862 on 75N91019F00111.
Is contract 75N91019F00111 an order under another contract?
Yes. 75N91019F00111 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract 75N91019F00111 competed?
The extent of competition for 75N91019F00111 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award